COST-EFFECTIVENESS ANALYSIS OF RALTEGRAVIR IN HIV-INFECTED TREATMENT NAIVE PATIENTS IN GREECE

被引：1
|
作者：
Athanasakis, K. [1 ]
Boubouchairopoulou, N. [1 ]
Retsa, M. P. [2 ]
Maiese, E. M. [3 ]
Elbasha, E. H. [4 ]
Kyriopoulos, J. [1 ]
机构：
[1] Natl Sch Publ Hlth, Athens, Greece
[2] MSD Hellas, Athens, Greece
[3] Merck & Co Inc, Whitehouse Stn, NJ USA
[4] Merck & Co Inc, Flourtown, PA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2506
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN65
引用
收藏
页码：A675 / A675
页数：1
相关论文
共 50 条
  • [1] COST-UTILITY ANALYSIS OF RALTEGRAVIR IN HIV-INFECTED TREATMENT NAIVE PATIENTS IN SWEDEN
    Chaudhary, M.
    Elbasha, E. H.
    Kumar, R. N.
    Lundberg, J.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A119 - A119
  • [2] Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis
    Sax, PE
    Islam, R
    Walensky, RP
    Losina, E
    Weinstein, MC
    Goldie, SJ
    Sadownik, SN
    Freedberg, KA
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) : 1316 - 1323
  • [3] COST-EFFECTIVENESS ANALYSIS OF EARLY ZIDOVUDINE TREATMENT OF HIV-INFECTED PATIENTS
    ODDONE, EZ
    COWPER, P
    HAMILTON, JD
    MATCHAR, DB
    HARTIGAN, P
    SAMSA, G
    SIMBERKOFF, M
    FEUSSNER, JR
    [J]. BRITISH MEDICAL JOURNAL, 1993, 307 (6915): : 1322 - 1325
  • [4] Raltegravir - a new agent in HIV-infected treatment-naive patients?
    Dabrowska, Magdalena Monika
    Wiercinska-Drapalo, Alicja
    [J]. HIV & AIDS REVIEW, 2009, 8 (04): : 5 - 7
  • [5] CARDIOVASCULAR DISEASE SCREENING IN HIV-INFECTED PATIENTS - A COST-EFFECTIVENESS ANALYSIS
    Nolte, J. E. H.
    Neumann, T.
    Neumann, A.
    Manne, J.
    Mostardt, S.
    Abbara, S.
    Brady, T. J.
    Hoffmann, U.
    Gazelle, G. S.
    Wasem, J.
    Goehler, A.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A8 - A8
  • [6] Cost-Effectiveness Analysis of Raltegravir in Treatment-Experienced HIV Type 1-Infected Patients in Spain
    Chaudhary, Mohammad A.
    Moreno, Santiago
    Kumar, Ritesh N.
    Nocea, Gonzalo
    Elbasha, Elamin
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (07) : 679 - 689
  • [7] Cost-effectiveness of drug resistance testing for the adaptation of treatment in HIV-infected patients
    Mühlberger, N
    Corzillius, M
    Sroczynski, G
    Siebert, U
    Peeters, J
    Wasem, J
    [J]. MEDICAL INFOBAHN FOR EUROPE, PROCEEDINGS, 2000, 77 : 160 - 160
  • [8] Cost-effectiveness of Raltegravir in Antiretroviral Treatment-Experienced HIV-1-Infected Patients in Switzerland
    Elbasha, E. E.
    Szucs, T.
    Chaudhary, M. A.
    Kumar, R. N.
    Roediger, A.
    Cook, J. R.
    Opravil, M.
    [J]. HIV CLINICAL TRIALS, 2009, 10 (04): : 233 - 253
  • [9] Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure
    Sendi, Pedram
    Guenthard, Huldrych F.
    Simcock, Mathew
    Ledergerber, Bruno
    Schuepbach, Joerg
    Battegay, Manuel
    [J]. PLOS ONE, 2007, 2 (01):
  • [10] Cost-effectiveness of raltegravir in HIV/AIDS
    Chaudhary, Mohammad Ashraf
    Elbasha, Elamin H.
    Kumar, Ritesh N.
    Nathanson, Esther C.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (06) : 627 - 639
12345